Table 1.
Variables for extraction
| Descriptive (study level) | Analytical (treatment-arm level) |
| Study ID | Study ID |
| Publication year | Treatment (category) |
| No. of participants randomised | Participants randomised (n) |
| Age (mean) | Participants followed for mortality (n) |
| Sex (% female) | Participants followed for CVD (n) |
| Baseline comorbidities | Follow-up duration (mean) |
| Cerebrovascular disease (%) | MACE (n) |
| Coronary artery disease (%) | Discontinuation (n) |
| Total CVD (%) | All-cause mortality (n) |
| Diabetes mellitus (%) | Cardiovascular mortality (n) |
| Intervention (drug and dose) | Stroke (n) |
| Control (drug and dose) | Myocardial infarction (n) |
| Funding | Heart failure (n) |
| Early termination | Acute kidney injury (n) |
| Reason for termination | Baseline SBP/DBP (mean) |
| Definition of MACE | Follow-up SBP/DBP (mean) |
| Definition other outcomes | SBP/DBP difference during follow-up (mean) |
| Comorbidity |
CVD, cardiovascular disease; DBP, diastolic blood pressure;; MACE, major adverse cardiovascular events; SBP, systolic blood pressure.